Parnell Pharmaceuticals Holdings Ltd

PARNF · OTC
Analyze with AI
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Operating Activities
Net Income-$1-$15-$7$130
Dep. & Amort.$5$1$2$2,653
Deferred Tax$0$0$0-$4,761
Stock-Based Comp.$0$0$0$0
Change in WC-$2-$4-$1-$4,849
Other Non-Cash$3$13$8$5,005
Operating Cash Flow$5-$5$2-$1,619
Investing Activities
PP&E Inv.-$1-$1-$1-$2,756
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$3-$3-$2$0
Investing Cash Flow-$4-$3-$3-$2,756
Financing Activities
Debt Repay.$1$14$1$7,851
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$1-$4$0-$1,695
Financing Cash Flow$0$9$1$6,156
Forex Effect-$1-$2-$0$240
Net Chg. in Cash$0-$0$0$2,022
Supplemental Information
Beg. Cash$4$5$4$2,379
End Cash$4$4$5$4,401
Free Cash Flow$5-$5$1-$4,375